​

Conduit Pharmaceuticals (MURF) Revenue & Revenue Breakdown

OverviewOwnershipFinancialsChart

Conduit Pharmaceuticals Revenue Highlights

0

Latest Revenue (Q)

$654.93M

Conduit Pharmaceuticals Revenue by Period

Conduit Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31-100.00%
2022-12-31-100.00%
2021-12-31--

Conduit Pharmaceuticals generated - in revenue during NA 2023, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

Conduit Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-29$654.93M8.37%
2024-06-30$604.34M12.82%
2024-03-31$535.67M100.00%
2023-12-31-100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31-100.00%
2022-12-31-100.00%
2022-09-30-100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31--

Conduit Pharmaceuticals generated $654.93M in revenue during Q3 2024, up 8.37% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

MURF Revenue FAQ

What is Conduit Pharmaceuticals’s yearly revenue?

Conduit Pharmaceuticals's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. MURF's yearly revenue for 2021 was $0, representing an increase of 0% compared to 2020.

What is Conduit Pharmaceuticals’s quarterly revenue?

Conduit Pharmaceuticals's quarterly revenue for Q3 2024 was $654.93M, a 8.37% increase from the previous quarter (Q2 2024), and a 0% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $604.34M, a 12.82% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). MURF's quarterly revenue for Q1 2024 was $535.68M, a 100.00% increase from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023).

What is Conduit Pharmaceuticals’s revenue growth rate?

Conduit Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 0%